Chad vs Israel: HIV-positive TB patients on ART (antiretroviral therapy)
Chad
100.0%
in 2024
Israel
100.0%
in 2024
Chad rank
1st
Israel rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Chad
- Israel
How they compare
Chad currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2015 it was Israel ahead.
Chad ranks 1st and Israel ranks 1st of 144 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Israel in 1.
Head to head by decade
| Decade | Chad | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.0% | 100.0% | 24.0% | Israel |
| 2020s | 99.4% | 98.2% | 1.2% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Chad or Israel?
- Chad, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Chad and Israel?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Israel?
- 9 years are reported by both, from 2015 to 2024.
- How do Chad and Israel rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Chad ranks 1st and Israel ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.